- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Hanmi Pharm Co Ltd (128940)
Hanmi Pharm Co Ltd stock price live, this page displays KS 128940 stock exchange data. View the 128940 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Hanmi Pharm Co Ltd real time stock price chart below.
What Is the Hanmi Pharm Co Ltd Stock Price Today?
The Hanmi Pharm Co Ltd stock price today is 533,000.
What Is the Stock Symbol for Hanmi Pharm Co Ltd?
The stock ticker symbol for Hanmi Pharm Co Ltd is 128940.
Is 128940 the Same as $128940?
$128940 is a common way to refer to the Hanmi Pharm Co Ltd ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Hanmi Pharm Co Ltd Trade On?
Hanmi Pharm Co Ltd is listed and trades on the Seoul stock exchange.
Is Hanmi Pharm Co Ltd a Good Stock to Buy?
Determining whether Hanmi Pharm Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Hanmi Pharm Co Ltd share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 128940 quote. (ISIN: KR7128940004)
What Is the Hanmi Pharm Co Ltd Stock Price Today?
The Hanmi Pharm Co Ltd stock price today is 533,000.
What Is the Stock Symbol for Hanmi Pharm Co Ltd?
The stock ticker symbol for Hanmi Pharm Co Ltd is 128940.
Is 128940 the Same as $128940?
$128940 is a common way to refer to the Hanmi Pharm Co Ltd ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Hanmi Pharm Co Ltd Trade On?
Hanmi Pharm Co Ltd is listed and trades on the Seoul stock exchange.
Is Hanmi Pharm Co Ltd a Good Stock to Buy?
Determining whether Hanmi Pharm Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Hanmi Pharm Co Ltd share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 128940 quote. (ISIN: KR7128940004)
Seoul
Currency in KRW
534,000
+22,000(+4.30%)
Delayed Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
520,000
546,000
52 wk Range
233,000
647,000
128940 is included in our AI-picked strategies. See how they work
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
520,000546,000
52 wk Range
233,000647,000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.40%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.40%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
128940 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
556,875
Upside
+4.28%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Hanmi Pharm. Co., Ltd., a biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally. It focuses on research areas with high unmet medical needs, including obesity, metabolism, oncology, and rare diseases. The company’s products include Gugutams, a urological combination therapy combining two active ingredients: tamsulosin, a treatment for Obstructive Prostatic Growth (OPG), and tadalafil, a treatment for erectile dysfunction (ED). The company has a research collaboration with MEDIC Life Sciences Inc. to identify cancer biomarkers. The company was founded in 1973 and is based in Hwaseong-si, South Korea.
Compare 128940 to Peers and Sector
Metrics to compare | 128940 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship128940PeersSector | |
|---|---|---|---|---|
P/E Ratio | 38.3x | 12.1x | −0.5x | |
PEG Ratio | 0.97 | 0.03 | 0.00 | |
Price / Book | 5.2x | 1.0x | 2.6x | |
Price / LTM Sales | 4.2x | 0.8x | 3.2x | |
Upside (Analyst Target) | 7.4% | 34.1% | 45.7% | |
Fair Value Upside | Unlock | 14.5% | 4.8% | Unlock |
Analyst Ratings
16 Buy
0 Hold
0 Sell
Ratings:
16 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 556,875
(+4.28% Upside)
Earnings
Latest Release
Feb 05, 2026
EPS / Forecast
3,780.00 / 2,133.00
Revenue / Forecast
433B / 397.48B
People Also Watch
FAQ
What Is the Hanmi Pharm Co (128940) Stock Price Today?
The Hanmi Pharm Co stock price today is 534,000 KRW.
What Stock Exchange Does Hanmi Pharm Co Trade On?
Hanmi Pharm Co is listed and trades on the Seoul Stock Exchange.
What Is the Stock Symbol for Hanmi Pharm Co?
The stock symbol for Hanmi Pharm Co is "128940."
Does Hanmi Pharm Co Pay Dividends? What’s The Current Dividend Yield?
The Hanmi Pharm Co dividend yield is 0.4%.
What Is the Hanmi Pharm Co Market Cap?
As of today, Hanmi Pharm Co market cap is 6.49T KRW.
What Is Hanmi Pharm Co's Earnings Per Share (TTM)?
The Hanmi Pharm Co EPS (TTM) is 13,362.
When Is the Next Hanmi Pharm Co Earnings Date?
Hanmi Pharm Co will release its next earnings report on May 05, 2026.
From a Technical Analysis Perspective, Is 128940 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Hanmi Pharm Co Stock Split?
Hanmi Pharm Co has split 15 times.
How Many Employees Does Hanmi Pharm Co Have?
Hanmi Pharm Co has 2400 employees.
What is the current trading status of Hanmi Pharm Co (128940)?
As of Apr 16, 2026, Hanmi Pharm Co (128940) is trading at a price of 534,000 KRW, with a previous close of 512,000 KRW. The stock has fluctuated within a day range of 520,000 KRW to 546,000 KRW, while its 52-week range spans from 233,000 KRW to 647,000 KRW.
What Is Hanmi Pharm Co (128940) Price Target According to Analysts?
The average 12-month price target for Hanmi Pharm Co is 556,875 KRW, with a high estimate of 720000 KRW and a low estimate of 370000 KRW. 16 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +4.28% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.